PhenID ::: Phen Description ::: phen description ::: NULL ::: NULL ::: NULL ::: NULL :::  :::  :::  ::: study subject ::: C0681850 ::: grup ::: 
phv00031628.v1  :::  How certain (0=Very uncertain; 5=moderately certain; 10=very certain) are you that you will be able to carry out  the following: test for acetone at least once/day ::: how certain 0= very uncertain  5=moderately certain  10=very certain  are you that you will be able to carry out the following  test for acetone at least once day ::: NULL ::: NULL ::: NULL ::: NULL ::: able (finding);does carry;laboratory procedures;acetone ::: C1299581;C0699809;C0022885;C0001002 ::: fndg;fndg;lbpr;orch,phsu ::: study subject ::: C0681850 ::: grup ::: Medication Patient;Lab Tests Patient;Medical History
phv00116366.v2  :::  ABO BLOOD TYPE ::: abo blood type ::: NULL ::: NULL ::: NULL ::: NULL ::: abo typing ::: C0200499 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00109264.v1  :::  DOES PTT USE AN ASSISTIVE DEVICE ::: does ptt use an assistive device ::: NULL ::: NULL ::: NULL ::: NULL ::: activated partial thromboplastin time measurement ::: C0030605 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00104712.v1  :::  DOES PTT USE A RIGHT ARM PROTHESIS ::: does ptt use a right arm prothesis ::: NULL ::: NULL ::: NULL ::: NULL ::: activated partial thromboplastin time measurement ::: C0030605 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00105809.v1  :::  DOES PTT USE A PROTHESIS ::: does ptt use a prothesis ::: NULL ::: NULL ::: NULL ::: NULL ::: activated partial thromboplastin time measurement ::: C0030605 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00115941.v2  :::  WHAT PTT WAS DOING WHEN INJURED -CODE3 ::: what ptt was doing when injured code3 ::: NULL ::: NULL ::: NULL ::: NULL ::: activated partial thromboplastin time measurement ::: C0030605 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00115939.v2  :::  WHAT PTT WAS DOING WHEN INJURED -CODE1 ::: what ptt was doing when injured code1 ::: NULL ::: NULL ::: NULL ::: NULL ::: activated partial thromboplastin time measurement ::: C0030605 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00105804.v1  :::  IS PTT MISSING A LIMB ::: is ptt missing a limb ::: NULL ::: NULL ::: NULL ::: NULL ::: activated partial thromboplastin time measurement ::: C0030605 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00110288.v1  :::  DOES PTT USE A RIGHT ARM PROTHESIS ::: does ptt use a right arm prothesis ::: NULL ::: NULL ::: NULL ::: NULL ::: activated partial thromboplastin time measurement ::: C0030605 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00101693.v1  :::  DOES PTT USE AN ASSISTIVE DEVICE ::: does ptt use an assistive device ::: NULL ::: NULL ::: NULL ::: NULL ::: activated partial thromboplastin time measurement ::: C0030605 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00110289.v1  :::  DOES PTT USE A LEFT LEG PROTHESIS ::: does ptt use a left leg prothesis ::: NULL ::: NULL ::: NULL ::: NULL ::: activated partial thromboplastin time measurement ::: C0030605 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00109271.v1  :::  IS PTT MISSING LEFT LEG ::: is ptt missing left leg ::: NULL ::: NULL ::: NULL ::: NULL ::: activated partial thromboplastin time measurement ::: C0030605 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00104711.v1  :::  DOES PTT USE A LEFT ARM PROTHESIS ::: does ptt use a left arm prothesis ::: NULL ::: NULL ::: NULL ::: NULL ::: activated partial thromboplastin time measurement ::: C0030605 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00115942.v2  :::  WHAT PTT WAS DOING WHEN INJURED -CODE4 ::: what ptt was doing when injured code4 ::: NULL ::: NULL ::: NULL ::: NULL ::: activated partial thromboplastin time measurement ::: C0030605 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00107482.v1  :::  DOES PTT USE A LEFT LEG PROTHESIS ::: does ptt use a left leg prothesis ::: NULL ::: NULL ::: NULL ::: NULL ::: activated partial thromboplastin time measurement ::: C0030605 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00113508.v2  :::  HOW OFTEN PTT FEELS THAT OTHERS CARE? Q 8 ::: how often ptt feels that others candidate gene association resource  q 8 ::: NULL ::: NULL ::: NULL ::: NULL ::: activated partial thromboplastin time measurement;emotions;mental association ::: C0030605;C0013987;C0004083 ::: lbpr;menp;menp ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Mental or Emotional Finding
phv00105799.v1  :::  CAN PTT DO A TANDEM STAND ::: can ptt do a tandem stand ::: NULL ::: NULL ::: NULL ::: NULL ::: activated partial thromboplastin time measurement;tandem;does stand ::: C0030605;C0075804;C0596013 ::: lbpr;orch,phsu;fndg ::: study subject ::: C0681850 ::: grup ::: Medication Patient;Lab Tests Patient;Daily or Recreational Activity
phv00124099.v1  :::  Adiponectin am (pg/mL) ::: adiponectin am pg m l ::: NULL ::: NULL ::: NULL ::: NULL ::: adiponectin measurement ::: C2700366 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00027119.v1  :::  Log of AER ::: logarithm of albumin-excretion rate ::: NULL ::: NULL ::: NULL ::: NULL ::: albumin excretion rate measurement ::: C0585937 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00081028.v1  :::  Albumin/Globulin Ratio ::: albumin globulin ratio ::: NULL ::: NULL ::: NULL ::: NULL ::: albumin/globulin ratio ::: C0201837 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00009578.v3  :::  BLOOD ANALYSIS - GLUCOSE - 2 HOUR POST ::: blood analysis glucose 2 hour post ::: NULL ::: NULL ::: NULL ::: NULL ::: analysis of substances;analysis;blood glucose measurement ::: C0002778;C0936012;C0392201 ::: lbpr;resa;lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Research Attributes
phv00001404.v1  ::: " BLOOD ANALYSIS, FASTING: VLDL BETA BAND " ::: blood analysis, fasting very low-density lipoprotein beta band ::: NULL ::: NULL ::: NULL ::: NULL ::: analysis of substances;analysis;fasting ::: C0002778;C0936012;C0015663 ::: lbpr;resa;fndg ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Research Attributes;Medical History
phv00001401.v1  ::: " BLOOD ANALYSIS, FASTING: BETA CHOLESTEROL (MG/100 ML) " ::: blood analysis, fasting beta cholesterol magnesium 100 mesiolingual ::: NULL ::: NULL ::: NULL ::: NULL ::: analysis of substances;analysis;fasting;serum total cholesterol measurement ::: C0002778;C0936012;C0015663;C1445957 ::: lbpr;resa;fndg;lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Research Attributes;Medical History
phv00002414.v1  ::: " BLOOD ANALYSIS, HEMATOCRIT " ::: blood analysis, hematocrit ::: NULL ::: NULL ::: NULL ::: NULL ::: analysis of substances;analysis;hematocrit procedure ::: C0002778;C0936012;C0018935 ::: lbpr;resa;lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Research Attributes
phv00001383.v1  :::  BLOOD ANALYSIS: SERUM PHOSPHOLIPID (MG/100 ML) ::: blood analysis  serum phospholipid  magnesium 100 mesiolingual ::: NULL ::: NULL ::: NULL ::: NULL ::: analysis of substances;analysis;serum magnesium finding ::: C0002778;C0936012;C1826990 ::: lbpr;resa;fndg ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Research Attributes
phv00113708.v2  :::  CHOLESTEROL ANALYSIS DATE ::: cholesterol analysis date ::: NULL ::: NULL ::: NULL ::: NULL ::: analysis of substances;date fruit;analysis;serum total cholesterol measurement ::: C0002778;C2348077;C0936012;C1445957 ::: lbpr;food;resa;lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Research Attributes
phv00007989.v3  :::  BLOOD ANALYSIS-FASTING LIPIDS: SINKING PRE-BETA BAND ::: blood analysis fasting lipids  sinking pre beta band ::: NULL ::: NULL ::: NULL ::: NULL ::: analysis of substances;fasting;analysis ::: C0002778;C0015663;C0936012 ::: lbpr;fndg;resa ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Research Attributes;Medical History
phv00001587.v1  ::: " BLOOD ANALYSIS: FASTING LIPIDS, CHOLESTEROL - BOTTOM FRACTION (ALPHA + BETA) (SEE VARIABLE #47 FOR DECK 141 CHOLESTEROL VALUES RECORDED IN SERUM OR PLASMA UNITS.) " ::: blood analysis fasting lipids, cholesterol bottom fraction alpha + beta see variable number 47 for deck 141 cholesterol values recorded in serum or plasma units ::: NULL ::: NULL ::: NULL ::: NULL ::: analysis of substances;fasting;analysis;serum total cholesterol measurement;vision ::: C0002778;C0015663;C0936012;C1445957;C0042789 ::: lbpr;fndg;resa;lbpr;orgf ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Research Attributes;Medical History
phv00007979.v3  :::  BLOOD ANALYSIS-FASTING LIPIDS ORIGIN TOP FRACTION (1.006) ::: blood analysis fasting lipids origin top fraction  1 006 ::: NULL ::: NULL ::: NULL ::: NULL ::: analysis of substances;fasting;national origin;analysis ::: C0002778;C0015663;C0079946;C0936012 ::: lbpr;fndg;clna;resa ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Research Attributes;Medical History
phv00001381.v1  :::  BLOOD ANALYSIS: BETA CHOLESTEROL (MG/100 ML) ::: blood analysis  beta cholesterol  magnesium 100 mesiolingual ::: NULL ::: NULL ::: NULL ::: NULL ::: analysis of substances;serum total cholesterol measurement;analysis;blood cholesterol ::: C0002778;C1445957;C0936012;C0518017 ::: lbpr;lbpr;resa;lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Research Attributes
phv00142303.v2  ::: " RNA LEVELS: APOA1, Run4, Platelet (TaqmanAssayID : Hs00163641_m1) " ::: ribonucleic acid levels apoa1, run4, platelet taqmanassayid hs00163641_m1 ::: NULL ::: NULL ::: NULL ::: NULL ::: apolipoprotein a1 measurement;platelet count measurement ::: C2698168;C0032181 ::: lbpr;lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00142225.v2  ::: " RNA LEVELS: CDKN2BAS, L, Run4, Leukocyte(AssaySequences:[forward primer: ACACAGTGCTCAAATCCATGATCT;reverse primer: CAAATTCCTGCCACTTCCTCTACT; probe: CATAGGTGGAGAACTTC]) " ::: ribonucleic acid levels cdkn2 bas, l, run4, leukocyte assaysequences forward primer acacagtgctcaaatccatgatct reverse primer caaattcctgccacttcctctact probe cataggtggagaacttc ::: NULL ::: NULL ::: NULL ::: NULL ::: beta-adrenergic stimulation, response to;dna probe method ::: C1862288;C1442917 ::: clna;lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00032680.v1  :::  Pre-lunch blood glucose at OD 340 (close-out) ::: pre lunch blood glucose at od 340   close out ::: NULL ::: NULL ::: NULL ::: NULL ::: blood glucose measurement;osteochondritis dissecans ::: C0392201;C0029421 ::: lbpr;dsyn ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Medical History
phv00032676.v1  :::  Pre-breakfast blood glucose at OD 340 (close-out) ::: pre breakfast blood glucose at od 340   close out ::: NULL ::: NULL ::: NULL ::: NULL ::: blood glucose measurement;osteochondritis dissecans ::: C0392201;C0029421 ::: lbpr;dsyn ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Medical History
phv00032899.v1  :::  Post-breakfast blood glucose at OD 340 (quarterly visit 11) ::: post breakfast blood glucose at od 340   quarterly visit 11 ::: NULL ::: NULL ::: NULL ::: NULL ::: blood glucose measurement;osteochondritis dissecans;health care visit ::: C0392201;C0029421;C1512346 ::: lbpr;dsyn;inbe ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Medical History
phv00033295.v1  :::  Post-breakfast blood glucose at OD 340 (quarterly visit 29) ::: post breakfast blood glucose at od 340   quarterly visit 29 ::: NULL ::: NULL ::: NULL ::: NULL ::: blood glucose measurement;osteochondritis dissecans;health care visit ::: C0392201;C0029421;C1512346 ::: lbpr;dsyn;inbe ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Medical History
phv00032771.v1  :::  Post-lunch blood glucose at OD 340 (quarterly visit 05) ::: post lunch blood glucose at od 340   quarterly visit 05 ::: NULL ::: NULL ::: NULL ::: NULL ::: blood glucose measurement;osteochondritis dissecans;health care visit ::: C0392201;C0029421;C1512346 ::: lbpr;dsyn;inbe ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Medical History
phv00032641.v1  :::  Pre-supper blood glucose at OD 340 (quarterly visit 00) ::: pre supper blood glucose at od 340   quarterly visit 00 ::: NULL ::: NULL ::: NULL ::: NULL ::: blood glucose measurement;osteochondritis dissecans;health care visit ::: C0392201;C0029421;C1512346 ::: lbpr;dsyn;inbe ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Medical History
phv00033033.v1  :::  Pre-lunch blood glucose at OD 340 (quarterly visit 17) ::: pre lunch blood glucose at od 340   quarterly visit 17 ::: NULL ::: NULL ::: NULL ::: NULL ::: blood glucose measurement;osteochondritis dissecans;health care visit ::: C0392201;C0029421;C1512346 ::: lbpr;dsyn;inbe ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Medical History
phv00033297.v1  :::  Pre-lunch blood glucose at OD 340 (quarterly visit 29) ::: pre lunch blood glucose at od 340   quarterly visit 29 ::: NULL ::: NULL ::: NULL ::: NULL ::: blood glucose measurement;osteochondritis dissecans;health care visit ::: C0392201;C0029421;C1512346 ::: lbpr;dsyn;inbe ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Medical History
phv00033259.v1  :::  Post-supper blood glucose at OD 340 (quarterly visit 27) ::: post supper blood glucose at od 340   quarterly visit 27 ::: NULL ::: NULL ::: NULL ::: NULL ::: blood glucose measurement;osteochondritis dissecans;health care visit ::: C0392201;C0029421;C1512346 ::: lbpr;dsyn;inbe ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Medical History
phv00032707.v1  :::  Pre-supper blood glucose at OD 340 (quarterly visit 02) ::: pre supper blood glucose at od 340   quarterly visit 02 ::: NULL ::: NULL ::: NULL ::: NULL ::: blood glucose measurement;osteochondritis dissecans;health care visit ::: C0392201;C0029421;C1512346 ::: lbpr;dsyn;inbe ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Medical History
phv00033329.v1  :::  3:00 a.m. blood glucose at OD 340 (quarterly visit 30) ::: 3 00 a m  blood glucose at od 340   quarterly visit 30 ::: NULL ::: NULL ::: NULL ::: NULL ::: blood glucose measurement;osteochondritis dissecans;health care visit ::: C0392201;C0029421;C1512346 ::: lbpr;dsyn;inbe ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Medical History
phv00032721.v1  :::  Pre-breakfast blood glucose at OD 340 (quarterly visit 03) ::: pre breakfast blood glucose at od 340   quarterly visit 03 ::: NULL ::: NULL ::: NULL ::: NULL ::: blood glucose measurement;osteochondritis dissecans;health care visit ::: C0392201;C0029421;C1512346 ::: lbpr;dsyn;inbe ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Medical History
phv00033411.v1  :::  Pre-supper blood glucose at OD 340 (quarterly visit 34) ::: pre supper blood glucose at od 340   quarterly visit 34 ::: NULL ::: NULL ::: NULL ::: NULL ::: blood glucose measurement;osteochondritis dissecans;health care visit ::: C0392201;C0029421;C1512346 ::: lbpr;dsyn;inbe ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Medical History
phv00033175.v1  :::  3:00 a.m. blood glucose at OD 340 (quarterly visit 23) ::: 3 00 a m  blood glucose at od 340   quarterly visit 23 ::: NULL ::: NULL ::: NULL ::: NULL ::: blood glucose measurement;osteochondritis dissecans;health care visit ::: C0392201;C0029421;C1512346 ::: lbpr;dsyn;inbe ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Medical History
phv00032831.v1  :::  Pre-breakfast blood glucose at OD 340 (quarterly visit 08) ::: pre breakfast blood glucose at od 340   quarterly visit 08 ::: NULL ::: NULL ::: NULL ::: NULL ::: blood glucose measurement;osteochondritis dissecans;health care visit ::: C0392201;C0029421;C1512346 ::: lbpr;dsyn;inbe ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Medical History
phv00032993.v1  :::  Pre-supper blood glucose at OD 340 (quarterly visit 15) ::: pre supper blood glucose at od 340   quarterly visit 15 ::: NULL ::: NULL ::: NULL ::: NULL ::: blood glucose measurement;osteochondritis dissecans;health care visit ::: C0392201;C0029421;C1512346 ::: lbpr;dsyn;inbe ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Medical History
phv00032845.v1  :::  3:00 a.m. blood glucose at OD 340 (quarterly visit 08) ::: 3 00 a m  blood glucose at od 340   quarterly visit 08 ::: NULL ::: NULL ::: NULL ::: NULL ::: blood glucose measurement;osteochondritis dissecans;health care visit ::: C0392201;C0029421;C1512346 ::: lbpr;dsyn;inbe ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Medical History
phv00032705.v1  :::  Post-lunch blood glucose at OD 340 (quarterly visit 02) ::: post lunch blood glucose at od 340   quarterly visit 02 ::: NULL ::: NULL ::: NULL ::: NULL ::: blood glucose measurement;osteochondritis dissecans;health care visit ::: C0392201;C0029421;C1512346 ::: lbpr;dsyn;inbe ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Medical History
phv00032779.v1  :::  3:00 a.m. blood glucose at OD 340 (quarterly visit 05) ::: 3 00 a m  blood glucose at od 340   quarterly visit 05 ::: NULL ::: NULL ::: NULL ::: NULL ::: blood glucose measurement;osteochondritis dissecans;health care visit ::: C0392201;C0029421;C1512346 ::: lbpr;dsyn;inbe ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Medical History
phv00033197.v1  :::  3:00 a.m. blood glucose at OD 340 (quarterly visit 24) ::: 3 00 a m  blood glucose at od 340   quarterly visit 24 ::: NULL ::: NULL ::: NULL ::: NULL ::: blood glucose measurement;osteochondritis dissecans;health care visit ::: C0392201;C0029421;C1512346 ::: lbpr;dsyn;inbe ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Medical History
phv00032635.v1  :::  Post-breakfast blood glucose at OD 340 (quarterly visit 00) ::: post breakfast blood glucose at od 340   quarterly visit 00 ::: NULL ::: NULL ::: NULL ::: NULL ::: blood glucose measurement;osteochondritis dissecans;health care visit ::: C0392201;C0029421;C1512346 ::: lbpr;dsyn;inbe ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Medical History
phv00032931.v1  :::  Bedtime blood glucose at OD 340 (quarterly visit 12) ::: bedtime blood glucose at od 340   quarterly visit 12 ::: NULL ::: NULL ::: NULL ::: NULL ::: blood glucose measurement;osteochondritis dissecans;health care visit ::: C0392201;C0029421;C1512346 ::: lbpr;dsyn;inbe ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Medical History
phv00031331.v1  :::  Experimental group: self blood glucose monitoring - less frequent daily schedule ::: experimental group  self blood glucose monitoring less frequent daily schedule ::: NULL ::: NULL ::: NULL ::: NULL ::: blood glucose measurement;preventive monitoring;clinical trials, monitoring ::: C0392201;C0150369;C1516647 ::: lbpr;hlca;resa ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Healthcare Activity Finding;Research Attributes
phv00027413.v1  :::  Mean blood glucose value taken from BG profile: quarterly visit 20 ::: mean blood glucose value taken from blood glucose profile  quarterly visit 20 ::: NULL ::: NULL ::: NULL ::: NULL ::: blood glucose measurement;profile (lab procedure);health care visit ::: C0392201;C1979963;C1512346 ::: lbpr;lbpr;inbe ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00007955.v3  :::  BLOOD ANALYSIS: SERUM POTASSIUM ::: blood analysis  serum potassium ::: NULL ::: NULL ::: NULL ::: NULL ::: blood potassium;analysis of substances;analysis;dietary potassium;serum potassium measurement ::: C0853173;C0002778;C0936012;C0162800;C0302353 ::: lbpr;lbpr;resa;food,inch;lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Substance Use History;Eating or Nutritional Finding;Research Attributes
phv00078515.v3  :::  High blood calcium ::: high blood calcium ::: NULL ::: NULL ::: NULL ::: NULL ::: calcium, increased level;blood calcium measurement ::: C0553702;C0729820 ::: fndg;lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00100043.v1  :::  UNADJUSTED CALCULATED LDL (mg/dl) ::: unadjusted calculated low-density lipoprotein  magnesium distolingual ::: NULL ::: NULL ::: NULL ::: NULL ::: calculated (procedure) ::: C1443182 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00160505.v1  :::  CALCULATED VLDL TRIGLYCERIDES (mg/dL) FROM NMR LIPOPROFILE-3 SPECTRAL ANALYSIS ::: calculated very low-density lipoprotein triglycerides magnesium d l  from nuclear magnetic resonance lipoprofile 3 spectral analysis ::: NULL ::: NULL ::: NULL ::: NULL ::: calculated (procedure);magnetic resonance imaging;analysis of substances;analysis ::: C1443182;C0024485;C0002778;C0936012 ::: lbpr;diap;lbpr;resa ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Research Attributes;Diagnostic Procedure
phv00163940.v1  :::  Values: EOMI_Case (Early MI case); EOMI_Control (Early MI control); LDL_High; LDL_Low ::: values  eomi_case  early myocardial infarction case   eomi_control  early myocardial infarction control   ldl_high  ldl_low ::: NULL ::: NULL ::: NULL ::: NULL ::: case control;myocardial infarction;serum ldl cholesterol measurement;myocardial infarction:finding:point in time:^patient:ordinal ::: C0872128;C0027051;C0428474;C2926063 ::: hlca;dsyn;lbpr;clna ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Healthcare Activity Finding;Research Attributes;Medical History
phv00171665.v1  :::  Year of the most recent study visit for which we have Leptin concentration ::: year of the most recent study visit for which we have leptin concentration ::: NULL ::: NULL ::: NULL ::: NULL ::: clinical trials;health care visit;study;mental concentration;leptin measurement ::: C0008976;C1512346;C2603343;C0086045;C1295176 ::: resa;inbe;resa;menp;lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Mental or Emotional Finding;Research Attributes
phv00171683.v1  :::  Year of the most recent study visit for which we have Total cholesterol ::: year of the most recent study visit for which we have total cholesterol ::: NULL ::: NULL ::: NULL ::: NULL ::: clinical trials;health care visit;study;serum total cholesterol measurement ::: C0008976;C1512346;C2603343;C1445957 ::: resa;inbe;resa;lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Research Attributes
phv00171663.v1  :::  Number of study visits for which we have Leptin concentration ::: number of study visits for which we have leptin concentration ::: NULL ::: NULL ::: NULL ::: NULL ::: clinical trials;study;mental concentration;leptin measurement ::: C0008976;C2603343;C0086045;C1295176 ::: resa;resa;menp;lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Mental or Emotional Finding;Research Attributes
phv00077361.v3  :::  CBC Visit type ::: complete blood count visit type ::: NULL ::: NULL ::: NULL ::: NULL ::: complete blood count;health care visit ::: C0009555;C1512346 ::: lbpr;inbe ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00077363.v3  :::  CBC Days since randomization/enrollment ::: complete blood count days since randomization enrollment ::: NULL ::: NULL ::: NULL ::: NULL ::: complete blood count;randomization;enrollment ::: C0009555;C0034656;C1516879 ::: lbpr;resa;hlca ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Healthcare Activity Finding;Research Attributes
phv00026602.v1  :::  Percentage of compliance with pre-supper (blood) tests ::: percentage of compliance with pre supper  blood  tests ::: NULL ::: NULL ::: NULL ::: NULL ::: compliance behavior;hematologic tests ::: C1321605;C0018941 ::: inbe;lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00170076.v1  :::  CK-MB within norm % or index ::: ckmb within norm % or index ::: NULL ::: NULL ::: NULL ::: NULL ::: creatine kinase mb measurement ::: C0523584 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00032571.v1  :::  CBL10: Form date for 24-hr urine tests ::: cbl10   form date for 24 heart rate urine tests ::: NULL ::: NULL ::: NULL ::: NULL ::: date fruit;laboratory procedures ::: C2348077;C0022885 ::: food;lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Clinical Attributes
phv00031219.v1  :::  Diabetes monitoring - one or two daily injection(s): blood test(s) should have done before breakfast ::: diabetes monitoring one or two daily injection s   blood test s  should have done before breakfast ::: NULL ::: NULL ::: NULL ::: NULL ::: diabetes monitoring check done;injection of therapeutic agent;hematologic tests;blood analysis (lab test);injection procedure ::: C0422587;C0021485;C0018941;C2121789;C1533685 ::: fndg;topp;lbpr;lbpr;topp ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Therapeutic or Preventive Procedure;Medical History
phv00025665.v1  :::  Diabetes monitoring (one or two daily injection[s]): blood test(s) done before lunch ::: diabetes monitoring  one or two daily injection s    blood test s  done before lunch ::: NULL ::: NULL ::: NULL ::: NULL ::: diabetes monitoring check done;injection of therapeutic agent;hematologic tests;blood analysis (lab test);injection procedure ::: C0422587;C0021485;C0018941;C2121789;C1533685 ::: fndg;topp;lbpr;lbpr;topp ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Therapeutic or Preventive Procedure;Medical History
phv00025995.v1  :::  Diabetes monitoring (three or more daily injections or infusion pump): blood test(s) should have done before lunch ::: diabetes monitoring  three or more daily injections or infusion pump   blood test s  should have done before lunch ::: NULL ::: NULL ::: NULL ::: NULL ::: diabetes monitoring check done;injection of therapeutic agent;injection procedure;hematologic tests;blood analysis (lab test) ::: C0422587;C0021485;C1533685;C0018941;C2121789 ::: fndg;topp;topp;lbpr;lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Therapeutic or Preventive Procedure;Medical History
phv00025651.v1  :::  Diabetes monitoring (three or more daily injections or infusion pump): blood test(s) done before lunch ::: diabetes monitoring  three or more daily injections or infusion pump   blood test s  done before lunch ::: NULL ::: NULL ::: NULL ::: NULL ::: diabetes monitoring check done;injection of therapeutic agent;injection procedure;hematologic tests;blood analysis (lab test) ::: C0422587;C0021485;C1533685;C0018941;C2121789 ::: fndg;topp;topp;lbpr;lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Therapeutic or Preventive Procedure;Medical History
phv00026011.v1  :::  Diabetes monitoring (one or two daily injection[s]): urine test(s) should have done before dinner ::: diabetes monitoring  one or two daily injection s    urine test s  should have done before dinner ::: NULL ::: NULL ::: NULL ::: NULL ::: diabetes monitoring check done;injection of therapeutic agent;urinalysis;injection procedure ::: C0422587;C0021485;C0042014;C1533685 ::: fndg;topp;lbpr;topp ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Therapeutic or Preventive Procedure;Medical History
phv00051127.v1  :::  C5. Diagnostic tests performed. Result of test 1 ::: c5  diagnostic tests performed  result of test 1 ::: NULL ::: NULL ::: NULL ::: NULL ::: diagnostic tests;laboratory procedures;experimental result ::: C0086143;C0022885;C2825142 ::: diap;lbpr;fndg ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Diagnostic Procedure
phv00015277.v1  ::: " F40.b. Oth DFA at Least 1 hour, (Participants with European ancestry). DIGS3 " ::: f40 b oth dfa at least 1 hour, participants with european ancestry digs3 ::: Ethnicity ::: ethnic european ::: C0239307 ::: popg ::: direct fluorescent antibody test ::: C1707759 ::: lbpr ::: participant ::: C0679646 ::: popg ::: Demographics;Lab Tests Patient
phv00172226.v1  :::  ELISA plate number for Lp-PLA2 Mass ::: enzyme-linked immunosorbent assay plate number for lppla2 mass ::: NULL ::: NULL ::: NULL ::: NULL ::: enzyme-linked immunosorbent assay;mass of body structure ::: C0014441;C0577559 ::: lbpr;fndg ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Medical History
phv00111135.v2  :::  F130 Type of Estrogen Assay ::: f130  type of estrogen assay ::: NULL ::: NULL ::: NULL ::: NULL ::: estrogens;biological assay;assay ::: C0014939;C0005507;C1510438 ::: horm,phsu,strd;lbpr;lbpr ::: study subject ::: C0681850 ::: grup ::: Medication Patient;Lab Tests Patient
phv00111160.v2  :::  F130 Days to Estrogen Assay ::: f130  days to estrogen assay ::: NULL ::: NULL ::: NULL ::: NULL ::: estrogens;biological assay;assay ::: C0014939;C0005507;C1510438 ::: horm,phsu,strd;lbpr;lbpr ::: study subject ::: C0681850 ::: grup ::: Medication Patient;Lab Tests Patient
phv00165200.v1  :::  Age in years at Factor VII measurement ::: age in years at factor vii measurement ::: Age ::: age ::: C0001779 ::: orga ::: factor vii measurement ::: C2825856 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Demographics;Lab Tests Patient
phv00165196.v1  :::  Blood fasting glucose at baseline in mg/dL ::: blood fasting glucose at baseline inmg d l ::: NULL ::: NULL ::: NULL ::: NULL ::: fasting blood glucose measurement ::: C0428568 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00066356.v1  :::  Fasting Blood Sugar ::: fasting blood sugar ::: NULL ::: NULL ::: NULL ::: NULL ::: fasting blood sugar measurement ::: C2825162 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00163552.v1  :::  Fasting glucose ::: fasting glucose ::: NULL ::: NULL ::: NULL ::: NULL ::: fasting;glucose;plasma glucose measurement ::: C0015663;C0017725;C0202042 ::: fndg;bacs,carb,phsu;lbpr ::: study subject ::: C0681850 ::: grup ::: Medication Patient;Lab Tests Patient;Medical History
phv00078569.v3  :::  Hemoccult test ever ::: hemoccult test ever ::: NULL ::: NULL ::: NULL ::: NULL ::: fecal occult blood test;laboratory procedures ::: C0201811;C0022885 ::: lbpr;lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00163981.v1  :::  Age in years at Fibrinogen measurement ::: age in years at fibrinogen measurement ::: Age ::: age ::: C0001779 ::: orga ::: fibrinogen assay ::: C0337428 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Demographics;Lab Tests Patient
phv00065989.v1  ::: " B5f. Health insurance coverage. If you currently have health insurance, does it provide coverage for blood glucose testing meters " ::: b5 f health insurance coverage if you currently have health insurance, does it provide coverage for blood glucose testing meters ::: NULL ::: NULL ::: NULL ::: NULL ::: fluorides;health insurance;provide (product);blood glucose measurement ::: C0016327;C0021682;C0359589;C0392201 ::: inch,phsu;hlca;food;lbpr ::: study subject ::: C0681850 ::: grup ::: Medication Patient;Lab Tests Patient;Eating or Nutritional Finding;Healthcare Activity Finding
phv00172254.v1  :::  Fructose + glucose + galactose ::: fructose + glucose + galactose ::: NULL ::: NULL ::: NULL ::: NULL ::: fructose;glucose;plasma glucose measurement ::: C0016745;C0017725;C0202042 ::: carb,phsu;bacs,carb,phsu;lbpr ::: study subject ::: C0681850 ::: grup ::: Medication Patient;Lab Tests Patient
phv00172169.v1  :::  Gamma glutamyltransferase (sample type: serum) ::: gamma glutamyltransferase  sample type  serum ::: NULL ::: NULL ::: NULL ::: NULL ::: gamma glutamyl transferase measurement ::: C0202035 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00066340.v1  ::: " Gender of participant has been confirmed with genotyping: 1 = Male, 2 = Female " ::: gender of participant has been confirmed with genotyping 1 = male, 2 = female ::: Gender ::: gender ::: C0079399 ::: orga;orga ::: gender:type:point in time:^patient:nominal;genotype determination;male gender;female ::: C0804628;C1285573;C0024554;C0015780 ::: clna;lbpr;fndg;fndg ::: participant ::: C0679646 ::: popg ::: Demographics;Lab Tests Patient;Medical History
phv00121977.v1  :::  The chip a sample was genotyped on (Platform) ::: the chip a sample was genotyped on  platform ::: NULL ::: NULL ::: NULL ::: NULL ::: genotype determination ::: C1285573 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00054359.v1  :::  SNP genotyping success rate: Y = at least 95% SNP genotyping success rate. (African American participants) ::: single nucleotide polymorphism genotyping success rate  y = at least 95% single nucleotide polymorphism genotyping success rate   african american participants ::: Marital Status;Race ::: single nucleotide polymorphism;african american ::: C0752046;C0085756 ::: nusq;popg ::: genotype determination ::: C1285573 ::: lbpr ::: participant ::: C0679646 ::: popg ::: Demographics;Lab Tests Patient
phv00073519.v1  :::  Sample IDs of samples being genotyped ::: sample ids of samples being genotyped ::: NULL ::: NULL ::: NULL ::: NULL ::: genotype determination ::: C1285573 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00073544.v2  :::  Sample genotyping instance ID ::: sample genotyping instance identification ::: NULL ::: NULL ::: NULL ::: NULL ::: genotype determination;identification (psychology) ::: C1285573;C0020792 ::: lbpr;menp ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Mental or Emotional Finding
phv00026497.v1  :::  CBL00: GFR serum glucose - pre-injection (mg/dl) ::: cbl00   glomerular filtration rate serum glucose pre injection  magnesium distolingual ::: NULL ::: NULL ::: NULL ::: NULL ::: glomerular filtration rate;serum magnesium finding;glucose;injection of therapeutic agent;injection procedure;plasma glucose measurement;glucose measurement, serum;glomerular filtration rate finding ::: C0017654;C1826990;C0017725;C0021485;C1533685;C0202042;C0202041;C1561549 ::: diap,ortf;fndg;bacs,carb,phsu;topp;topp;lbpr;lbpr;fndg ::: study subject ::: C0681850 ::: grup ::: Medication Patient;Lab Tests Patient;Therapeutic or Preventive Procedure;Diagnostic Procedure
phv00027347.v1  :::  CBL2: GFR serum glucose - t3 value (mg/dl) ::: cbl2  glomerular filtration rate serum glucose t3 value  magnesium distolingual ::: NULL ::: NULL ::: NULL ::: NULL ::: glomerular filtration rate;serum magnesium finding;glucose;plasma glucose measurement;glucose measurement, serum;glomerular filtration rate finding ::: C0017654;C1826990;C0017725;C0202042;C0202041;C1561549 ::: diap,ortf;fndg;bacs,carb,phsu;lbpr;lbpr;fndg ::: study subject ::: C0681850 ::: grup ::: Medication Patient;Lab Tests Patient;Diagnostic Procedure
phv00030371.v1  :::  CBL3: GFR serum glucose - t2 value (mg/dl) ::: cbl3  glomerular filtration rate serum glucose t2 value  magnesium distolingual ::: NULL ::: NULL ::: NULL ::: NULL ::: glomerular filtration rate;serum magnesium finding;glucose;plasma glucose measurement;glucose measurement, serum;glomerular filtration rate finding ::: C0017654;C1826990;C0017725;C0202042;C0202041;C1561549 ::: diap,ortf;fndg;bacs,carb,phsu;lbpr;lbpr;fndg ::: study subject ::: C0681850 ::: grup ::: Medication Patient;Lab Tests Patient;Diagnostic Procedure
phv00030986.v1  :::  CBL9: GFR serum glucose - t1 value (mg/dl) ::: cbl9  glomerular filtration rate serum glucose t1 value  magnesium distolingual ::: NULL ::: NULL ::: NULL ::: NULL ::: glomerular filtration rate;serum magnesium finding;glucose;plasma glucose measurement;glucose measurement, serum;glomerular filtration rate finding ::: C0017654;C1826990;C0017725;C0202042;C0202041;C1561549 ::: diap,ortf;fndg;bacs,carb,phsu;lbpr;lbpr;fndg ::: study subject ::: C0681850 ::: grup ::: Medication Patient;Lab Tests Patient;Diagnostic Procedure
phv00026660.v1  :::  CBL6: GFR gamma count serum - t4 ::: cbl6  glomerular filtration rate gamma count serum t4 ::: NULL ::: NULL ::: NULL ::: NULL ::: glomerular filtration rate;serum thyroxine;glomerular filtration rate finding ::: C0017654;C0036833;C1561549 ::: diap,ortf;lbpr;fndg ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Diagnostic Procedure
phv00031575.v1  :::  CBL4: GFR gamma count serum - t4 ::: cbl4  glomerular filtration rate gamma count serum t4 ::: NULL ::: NULL ::: NULL ::: NULL ::: glomerular filtration rate;serum thyroxine;glomerular filtration rate finding ::: C0017654;C0036833;C1561549 ::: diap,ortf;lbpr;fndg ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Diagnostic Procedure
phv00028515.v1  :::  CBL7: GFR serum glucose - t4 value (mg/dl) ::: cbl7  glomerular filtration rate serum glucose t4 value  magnesium distolingual ::: NULL ::: NULL ::: NULL ::: NULL ::: glomerular filtration rate;serum thyroxine;glucose;plasma glucose measurement;glomerular filtration rate finding ::: C0017654;C0036833;C0017725;C0202042;C1561549 ::: diap,ortf;lbpr;bacs,carb,phsu;lbpr;fndg ::: study subject ::: C0681850 ::: grup ::: Medication Patient;Lab Tests Patient;Diagnostic Procedure
phv00048507.v1  :::  GFR (glomerular filtration rate) urine-volume: t-1 ::: glomerular filtration rate  glomerular filtration rate  urine volume  t1 ::: NULL ::: NULL ::: NULL ::: NULL ::: glomerular filtration rate;urine volume function;urine sample volume measurement;urine volume finding;glomerular filtration rate finding ::: C0017654;C0232856;C1278293;C1287298;C1561549 ::: diap,ortf;clna;lbpr;fndg;fndg ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Diagnostic Procedure;Medical History
phv00171640.v1  :::  2-hour glucose concentration at the first study visit ::: 2hour glucose concentration at the first study visit ::: NULL ::: NULL ::: NULL ::: NULL ::: glucose concentration, test strip measurement;clinical trials;health care visit;study ::: C0427743;C0008976;C1512346;C2603343 ::: lbpr;resa;inbe;resa ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Research Attributes
phv00049991.v1  ::: " J6a1. Potential contributing factors,  glucose monitoring: self blood glucose " ::: j6a1 potential contributing factors, glucose monitoring self blood glucose ::: NULL ::: NULL ::: NULL ::: NULL ::: glucose measurement by monitoring device;blood glucose measurement ::: C0202048;C0392201 ::: lbpr;lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Substance Use History
phv00118398.v2  ::: " 3ML GRAY TUBE, 1ML SERUM(2 HR GLUCOSE). Q 28 " ::: 3ml gray tube, 1ml serum 2 heart rate glucose q 28 ::: NULL ::: NULL ::: NULL ::: NULL ::: glucose measurement, serum ::: C0202041 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Clinical Attributes
phv00029075.v1  :::  Standard treatment: performs urine glucose monitoring ::: standard treatment  performs urine glucose monitoring ::: NULL ::: NULL ::: NULL ::: NULL ::: glucose measurement, urine;preventive monitoring;clinical trials, monitoring;glycosuria;glucose measurement by monitoring device;perform;therapeutic procedure;administration procedure ::: C0004076;C0150369;C1516647;C0017979;C0202048;C2947996;C0087111;C1533734 ::: lbpr;hlca;resa;fndg;lbpr;phsu;topp;topp ::: study subject ::: C0681850 ::: grup ::: Medication Patient;Lab Tests Patient;Healthcare Activity Finding;Therapeutic or Preventive Procedure;Research Attributes;Daily or Recreational Activity
phv00001391.v1  ::: " GLUCOSE CHALLENGE: TIME OF LAST EATING, AM OR PM " ::: glucose challenge time of last eating, am or pm ::: NULL ::: NULL ::: NULL ::: NULL ::: glucose;challenge:type:point in time:^patient:nominal;challenge;plasma glucose measurement;eating ::: C0017725;C0798503;C0805586;C0202042;C0013470 ::: bacs,carb,phsu;clna;hlca;lbpr;orgf ::: study subject ::: C0681850 ::: grup ::: Medication Patient;Lab Tests Patient;Self-care Status;Healthcare Activity Finding;Medical History
phv00126016.v1  :::  Glucose fasting status ::: glucose fasting status ::: NULL ::: NULL ::: NULL ::: NULL ::: glucose;fasting status;plasma glucose measurement ::: C0017725;C1976106;C0202042 ::: bacs,carb,phsu;fndg;lbpr ::: study subject ::: C0681850 ::: grup ::: Medication Patient;Lab Tests Patient
phv00126331.v1  :::  LFFQ: glucose (gm) ::: lffq  glucose  gm ::: NULL ::: NULL ::: NULL ::: NULL ::: glucose;plasma glucose measurement ::: C0017725;C0202042 ::: bacs,carb,phsu;lbpr ::: study subject ::: C0681850 ::: grup ::: Medication Patient;Lab Tests Patient
phv00126182.v1  :::  Glucose (g) ::: glucose  gram ::: NULL ::: NULL ::: NULL ::: NULL ::: glucose;plasma glucose measurement ::: C0017725;C0202042 ::: bacs,carb,phsu;lbpr ::: study subject ::: C0681850 ::: grup ::: Medication Patient;Lab Tests Patient
phv00112339.v1  :::  Baby's cord glucose ::: baby s cord glucose ::: NULL ::: NULL ::: NULL ::: NULL ::: glucose;plasma glucose measurement ::: C0017725;C0202042 ::: bacs,carb,phsu;lbpr ::: study subject ::: C0681850 ::: grup ::: Medication Patient;Lab Tests Patient
phv00100051.v1  :::  2 HR GLUCOSE (mg/dl) ::: 2 heart rate glucose  magnesium distolingual ::: NULL ::: NULL ::: NULL ::: NULL ::: glucose;plasma glucose measurement ::: C0017725;C0202042 ::: bacs,carb,phsu;lbpr ::: study subject ::: C0681850 ::: grup ::: Medication Patient;Lab Tests Patient;Clinical Attributes
phv00094122.v1  :::  GLUCOSE (VALUE IN MG/DL)          Q4A ::: glucose  value in magnesium distolingual  q4 a ::: NULL ::: NULL ::: NULL ::: NULL ::: glucose;plasma glucose measurement ::: C0017725;C0202042 ::: bacs,carb,phsu;lbpr ::: study subject ::: C0681850 ::: grup ::: Medication Patient;Lab Tests Patient
phv00032798.v1  :::  Bedtime blood glucose mg/dl (quarterly visit 06) ::: bedtime blood glucose magnesium distolingual  quarterly visit 06 ::: NULL ::: NULL ::: NULL ::: NULL ::: glucose;plasma glucose measurement;blood glucose measurement;health care visit ::: C0017725;C0202042;C0392201;C1512346 ::: bacs,carb,phsu;lbpr;lbpr;inbe ::: study subject ::: C0681850 ::: grup ::: Medication Patient;Lab Tests Patient
phv00032836.v1  :::  Post-lunch blood glucose mg/dl (quarterly visit 08) ::: post lunch blood glucose magnesium distolingual  quarterly visit 08 ::: NULL ::: NULL ::: NULL ::: NULL ::: glucose;plasma glucose measurement;blood glucose measurement;health care visit ::: C0017725;C0202042;C0392201;C1512346 ::: bacs,carb,phsu;lbpr;lbpr;inbe ::: study subject ::: C0681850 ::: grup ::: Medication Patient;Lab Tests Patient
phv00033162.v1  :::  Post-breakfast blood glucose mg/dl (quarterly visit 23) ::: post breakfast blood glucose magnesium distolingual  quarterly visit 23 ::: NULL ::: NULL ::: NULL ::: NULL ::: glucose;plasma glucose measurement;blood glucose measurement;health care visit ::: C0017725;C0202042;C0392201;C1512346 ::: bacs,carb,phsu;lbpr;lbpr;inbe ::: study subject ::: C0681850 ::: grup ::: Medication Patient;Lab Tests Patient
phv00032886.v1  :::  Bedtime blood glucose mg/dl (quarterly visit 10) ::: bedtime blood glucose magnesium distolingual  quarterly visit 10 ::: NULL ::: NULL ::: NULL ::: NULL ::: glucose;plasma glucose measurement;blood glucose measurement;health care visit ::: C0017725;C0202042;C0392201;C1512346 ::: bacs,carb,phsu;lbpr;lbpr;inbe ::: study subject ::: C0681850 ::: grup ::: Medication Patient;Lab Tests Patient
phv00032774.v1  :::  Post-supper blood glucose mg/dl (quarterly visit 05) ::: post supper blood glucose magnesium distolingual  quarterly visit 05 ::: NULL ::: NULL ::: NULL ::: NULL ::: glucose;plasma glucose measurement;blood glucose measurement;health care visit ::: C0017725;C0202042;C0392201;C1512346 ::: bacs,carb,phsu;lbpr;lbpr;inbe ::: study subject ::: C0681850 ::: grup ::: Medication Patient;Lab Tests Patient
phv00032926.v1  :::  Pre-supper blood glucose mg/dl (quarterly visit 12) ::: pre supper blood glucose magnesium distolingual  quarterly visit 12 ::: NULL ::: NULL ::: NULL ::: NULL ::: glucose;plasma glucose measurement;blood glucose measurement;health care visit ::: C0017725;C0202042;C0392201;C1512346 ::: bacs,carb,phsu;lbpr;lbpr;inbe ::: study subject ::: C0681850 ::: grup ::: Medication Patient;Lab Tests Patient
phv00033232.v1  :::  Post-lunch blood glucose mg/dl (quarterly visit 26) ::: post lunch blood glucose magnesium distolingual  quarterly visit 26 ::: NULL ::: NULL ::: NULL ::: NULL ::: glucose;plasma glucose measurement;blood glucose measurement;health care visit ::: C0017725;C0202042;C0392201;C1512346 ::: bacs,carb,phsu;lbpr;lbpr;inbe ::: study subject ::: C0681850 ::: grup ::: Medication Patient;Lab Tests Patient
phv00032990.v1  :::  Post-lunch blood glucose mg/dl (quarterly visit 15) ::: post lunch blood glucose magnesium distolingual  quarterly visit 15 ::: NULL ::: NULL ::: NULL ::: NULL ::: glucose;plasma glucose measurement;blood glucose measurement;health care visit ::: C0017725;C0202042;C0392201;C1512346 ::: bacs,carb,phsu;lbpr;lbpr;inbe ::: study subject ::: C0681850 ::: grup ::: Medication Patient;Lab Tests Patient
phv00033408.v1  :::  Post-lunch blood glucose mg/dl (quarterly visit 34) ::: post lunch blood glucose magnesium distolingual  quarterly visit 34 ::: NULL ::: NULL ::: NULL ::: NULL ::: glucose;plasma glucose measurement;blood glucose measurement;health care visit ::: C0017725;C0202042;C0392201;C1512346 ::: bacs,carb,phsu;lbpr;lbpr;inbe ::: study subject ::: C0681850 ::: grup ::: Medication Patient;Lab Tests Patient
phv00033362.v1  :::  Pre-lunch blood glucose mg/dl (quarterly visit 32) ::: pre lunch blood glucose magnesium distolingual  quarterly visit 32 ::: NULL ::: NULL ::: NULL ::: NULL ::: glucose;plasma glucose measurement;blood glucose measurement;health care visit ::: C0017725;C0202042;C0392201;C1512346 ::: bacs,carb,phsu;lbpr;lbpr;inbe ::: study subject ::: C0681850 ::: grup ::: Medication Patient;Lab Tests Patient
phv00033498.v1  :::  Pre-supper blood glucose mg/dl (quarterly visit 38) ::: pre supper blood glucose magnesium distolingual  quarterly visit 38 ::: NULL ::: NULL ::: NULL ::: NULL ::: glucose;plasma glucose measurement;blood glucose measurement;health care visit ::: C0017725;C0202042;C0392201;C1512346 ::: bacs,carb,phsu;lbpr;lbpr;inbe ::: study subject ::: C0681850 ::: grup ::: Medication Patient;Lab Tests Patient
phv00033032.v1  :::  Pre-lunch blood glucose mg/dl (quarterly visit 17) ::: pre lunch blood glucose magnesium distolingual  quarterly visit 17 ::: NULL ::: NULL ::: NULL ::: NULL ::: glucose;plasma glucose measurement;blood glucose measurement;health care visit ::: C0017725;C0202042;C0392201;C1512346 ::: bacs,carb,phsu;lbpr;lbpr;inbe ::: study subject ::: C0681850 ::: grup ::: Medication Patient;Lab Tests Patient
phv00032632.v1  :::  Pre-breakfast blood glucose mg/dl (quarterly visit 00) ::: pre breakfast blood glucose magnesium distolingual  quarterly visit 00 ::: NULL ::: NULL ::: NULL ::: NULL ::: glucose;plasma glucose measurement;blood glucose measurement;health care visit ::: C0017725;C0202042;C0392201;C1512346 ::: bacs,carb,phsu;lbpr;lbpr;inbe ::: study subject ::: C0681850 ::: grup ::: Medication Patient;Lab Tests Patient
phv00032794.v1  :::  Pre-supper blood glucose mg/dl (quarterly visit 06) ::: pre supper blood glucose magnesium distolingual  quarterly visit 06 ::: NULL ::: NULL ::: NULL ::: NULL ::: glucose;plasma glucose measurement;blood glucose measurement;health care visit ::: C0017725;C0202042;C0392201;C1512346 ::: bacs,carb,phsu;lbpr;lbpr;inbe ::: study subject ::: C0681850 ::: grup ::: Medication Patient;Lab Tests Patient
phv00033082.v1  :::  Post-supper blood glucose mg/dl (quarterly visit 19) ::: post supper blood glucose magnesium distolingual  quarterly visit 19 ::: NULL ::: NULL ::: NULL ::: NULL ::: glucose;plasma glucose measurement;blood glucose measurement;health care visit ::: C0017725;C0202042;C0392201;C1512346 ::: bacs,carb,phsu;lbpr;lbpr;inbe ::: study subject ::: C0681850 ::: grup ::: Medication Patient;Lab Tests Patient
phv00033414.v1  :::  Bedtime blood glucose mg/dl (quarterly visit 34) ::: bedtime blood glucose magnesium distolingual  quarterly visit 34 ::: NULL ::: NULL ::: NULL ::: NULL ::: glucose;plasma glucose measurement;blood glucose measurement;health care visit ::: C0017725;C0202042;C0392201;C1512346 ::: bacs,carb,phsu;lbpr;lbpr;inbe ::: study subject ::: C0681850 ::: grup ::: Medication Patient;Lab Tests Patient
phv00030736.v1  :::  T31-blood glucose profile (bgp) 7 - mg/dl ::: t31  blood glucose profile  bgp  7 magnesium distolingual ::: NULL ::: NULL ::: NULL ::: NULL ::: glucose;profile (lab procedure);plasma glucose measurement;blood glucose measurement ::: C0017725;C1979963;C0202042;C0392201 ::: bacs,carb,phsu;lbpr;lbpr;lbpr ::: study subject ::: C0681850 ::: grup ::: Medication Patient;Lab Tests Patient
phv00033264.v1  :::  Blood glucose profile 8 - mg/dl (quarterly visit 27) ::: blood glucose profile 8 magnesium distolingual  quarterly visit 27 ::: NULL ::: NULL ::: NULL ::: NULL ::: glucose;profile (lab procedure);plasma glucose measurement;blood glucose measurement;health care visit ::: C0017725;C1979963;C0202042;C0392201;C1512346 ::: bacs,carb,phsu;lbpr;lbpr;lbpr;inbe ::: study subject ::: C0681850 ::: grup ::: Medication Patient;Lab Tests Patient
phv00126817.v1  :::  LFFQ: glutamic acid (gm) ::: lffq  glutamic acid  gm ::: NULL ::: NULL ::: NULL ::: NULL ::: glutamic acid;glutamate measurement ::: C0061472;C0523665 ::: aapp,bacs,phsu;lbpr ::: study subject ::: C0681850 ::: grup ::: Medication Patient;Lab Tests Patient
phv00050651.v1  :::  B8c3. Health care delivery. Other blood tests: paid other insurance ::: b8c3   health candidate gene association resource delivery  other blood tests  paid other insurance ::: NULL ::: NULL ::: NULL ::: NULL ::: health insurance;mental association;obstetric delivery;others;hematologic tests;delivery finding ::: C0021682;C0004083;C0011209;C1955473;C0018941;C0559563 ::: hlca;menp;topp;fndg;lbpr;fndg ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Mental or Emotional Finding;Healthcare Activity Finding;Therapeutic or Preventive Procedure;Medical History
phv00094454.v1  :::  HEMATOCRIT                           Q5 ::: hematocrit q5 ::: NULL ::: NULL ::: NULL ::: NULL ::: hematocrit procedure ::: C0018935 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00106920.v1  :::  HEMATOCRIT (%) ::: hematocrit  % ::: NULL ::: NULL ::: NULL ::: NULL ::: hematocrit procedure ::: C0018935 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00165217.v1  :::  Hematocrit at designated visit (may not be baseline) in % ::: hematocrit at designated visit  may not be baseline  in % ::: NULL ::: NULL ::: NULL ::: NULL ::: hematocrit procedure;health care visit ::: C0018935;C1512346 ::: lbpr;inbe ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00021934.v3  :::  HOMOCYSTEINE ::: homocysteine ::: NULL ::: NULL ::: NULL ::: NULL ::: homocystine measurement;homocysteine measurement ::: C0919377;C2242817 ::: lbpr;lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00024660.v3  :::  HOMOCYSTEINE (UMOL/L) ::: homocysteine  umol l ::: NULL ::: NULL ::: NULL ::: NULL ::: homocystine measurement;homocysteine measurement ::: C0919377;C2242817 ::: lbpr;lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00121021.v2  :::  Y0 HOMOCYSTEINE (umol/L) - 2003 RUN ::: y0 homocysteine umol  l  2003  run ::: NULL ::: NULL ::: NULL ::: NULL ::: homocystine measurement;homocysteine measurement;running (physical activity);does run (finding) ::: C0919377;C2242817;C0035953;C0600140 ::: lbpr;lbpr;dora;fndg ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Daily or Recreational Activity
phv00066107.v1  ::: " D4h. Hospitalization and other health care services used. During the past 12 months, have you had any of the following laboratory tests: dilated eye, in past 12 months " ::: d4 h hospitalization and other health candidate gene association resource services used during the past 12 months, have you had any of the following laboratory tests dilated eye, in past 12 months ::: NULL ::: NULL ::: NULL ::: NULL ::: hospitalization;health services;mental association;used by;laboratory procedures;dilate eye ::: C0019993;C0018747;C0004083;C1273517;C0022885;C0849420 ::: hlca;hlca;menp;fndg;lbpr;topp ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Mental or Emotional Finding;Healthcare Activity Finding;Therapeutic or Preventive Procedure
phv00050919.v1  ::: " D4g1. Hospitalization and other health care services used. During the past 12months, have you had any of the following laboratory tests: stress test -number of times " ::: d4g1 hospitalization and other health candidate gene association resource services used during the past 12 months, have you had any of the following laboratory tests stress test number of times ::: NULL ::: NULL ::: NULL ::: NULL ::: hospitalization;health services;mental association;used by;laboratory procedures;exercise stress test ::: C0019993;C0018747;C0004083;C1273517;C0022885;C0015260 ::: hlca;hlca;menp;fndg;lbpr;diap ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Mental or Emotional Finding;Healthcare Activity Finding;Diagnostic Procedure
phv00050912.v1  ::: " D4d. Hospitalization and other health care services used. During the past 12months, have you had any of the following laboratory tests: fasting lipid test " ::: d4 d hospitalization and other health candidate gene association resource services used during the past 12 months, have you had any of the following laboratory tests fasting lipid test ::: NULL ::: NULL ::: NULL ::: NULL ::: hospitalization;health services;mental association;used by;laboratory procedures;fasting ::: C0019993;C0018747;C0004083;C1273517;C0022885;C0015663 ::: hlca;hlca;menp;fndg;lbpr;fndg ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Mental or Emotional Finding;Healthcare Activity Finding;Medical History
phv00050930.v1  ::: " D4m. Hospitalization and other health care services used. During the past 12months, have you had any of the following laboratory tests: other urine tests " ::: d4 m hospitalization and other health candidate gene association resource services used during the past 12 months, have you had any of the following laboratory tests other urine tests ::: NULL ::: NULL ::: NULL ::: NULL ::: hospitalization;health services;mental association;used by;laboratory procedures;others ::: C0019993;C0018747;C0004083;C1273517;C0022885;C1955473 ::: hlca;hlca;menp;fndg;lbpr;fndg ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Mental or Emotional Finding;Healthcare Activity Finding
phv00010094.v3  :::  DID YOU EVER HAVE HIGH BLOOD CHOLESTEROL (> 240 MG/DL) ::: did you ever have high blood cholesterol  > 240  magnesium distolingual ::: NULL ::: NULL ::: NULL ::: NULL ::: hypercholesterolemia result;blood cholesterol ::: C1522133;C0518017 ::: fndg;lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00073694.v4  :::  Immunophenotype & Cytochemistry: CD15 ::: immunophenotype & cytochemistry  cd15 ::: NULL ::: NULL ::: NULL ::: NULL ::: immunophenotyping ::: C0079611 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00163819.v2  :::  Immunophenotype & Cytochemistry: CD3 % Positive ::: immunophenotype & cytochemistry  cd3 % positive ::: NULL ::: NULL ::: NULL ::: NULL ::: immunophenotyping;cd3 expressing t cell count;positive finding ::: C0079611;C2698592;C1514241 ::: lbpr;lbpr;fndg ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00163823.v2  :::  Immunophenotype & Cytochemistry: CD13 % Positive ::: immunophenotype & cytochemistry  cd13  % positive ::: NULL ::: NULL ::: NULL ::: NULL ::: immunophenotyping;positive finding ::: C0079611;C1514241 ::: lbpr;fndg ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00163886.v2  :::  :TEL-AML1: For FISH tested indicate % ::: tel aml1  for fluorescent in situ hybridization tested indicate % ::: NULL ::: NULL ::: NULL ::: NULL ::: in situ hybridization;indicated ::: C0162788;C1444656 ::: lbpr,mbrt;fndg ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00163883.v2  :::  :MLL: For FISH tested indicate % ::: mixed lineage leukemia  for fluorescent in situ hybridization tested indicate % ::: NULL ::: NULL ::: NULL ::: NULL ::: in situ hybridization;indicated ::: C0162788;C1444656 ::: lbpr,mbrt;fndg ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00070362.v4  ::: " INSULIN, PMOL/L (ELISA RESULTS WERE MULTIPLIED BY A FACTOR OF 6 TO GET PMOL/L UNITS FOR INSULIN) " ::: insulin, pmol l enzyme-linked immunosorbent assay results were multiplied by a factor of 6 to get pmol l units for insulin ::: NULL ::: NULL ::: NULL ::: NULL ::: insulin;recombinant insulin;enzyme-linked immunosorbent assay ::: C0021641;C1533581;C0014441 ::: aapp,horm,phsu;aapp,horm,phsu;lbpr ::: study subject ::: C0681850 ::: grup ::: Medication Patient;Lab Tests Patient
phv00023796.v3  :::  INTERLEUKIN-6 FROM SERUM (PG/ML) ::: interleukin 6 from serum  pg mesiolingual ::: NULL ::: NULL ::: NULL ::: NULL ::: interleukin 6 measurement;recombinant interleukin-6 ::: C0919829;C1527132 ::: lbpr;aapp,imft,phsu ::: study subject ::: C0681850 ::: grup ::: Medication Patient;Lab Tests Patient
phv00159437.v2  ::: " 1st, 2nd, 3rd, etc. culture taken for a particular subject. " ::: 1st, 2nd, 3rd, etc culture taken for a particular subject ::: NULL ::: NULL ::: NULL ::: NULL ::: laboratory culture;microbial culture (procedure) ::: C0430400;C2242979 ::: lbpr;lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00031767.v1  :::  CBL5: Lipid test - 24: collection date ::: cbl5  lipid test 24  collection date ::: NULL ::: NULL ::: NULL ::: NULL ::: laboratory procedures ::: C0022885 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00031103.v1  :::  CBL8: Lipid test - 24: collection date ::: cbl8  lipid test 24  collection date ::: NULL ::: NULL ::: NULL ::: NULL ::: laboratory procedures ::: C0022885 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00027395.v1  :::  CBL2: Lipid test - 24: collection date ::: cbl2  lipid test 24  collection date ::: NULL ::: NULL ::: NULL ::: NULL ::: laboratory procedures ::: C0022885 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00028562.v1  :::  CBL7: Lipid test - 24: collection date ::: cbl7  lipid test 24  collection date ::: NULL ::: NULL ::: NULL ::: NULL ::: laboratory procedures ::: C0022885 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00030416.v1  :::  CBL3: Lipid test - 21: collection date ::: cbl3  lipid test 21  collection date ::: NULL ::: NULL ::: NULL ::: NULL ::: laboratory procedures ::: C0022885 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00031757.v1  :::  CBL5: Renal test - 19: raw clearance value (ml/mn) ::: cbl5  renal test 19  raw clearance value  mesiolingual mn ::: NULL ::: NULL ::: NULL ::: NULL ::: laboratory procedures;renal clearance diagnostic test ::: C0022885;C0699829 ::: lbpr;diap ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Diagnostic Procedure
phv00027384.v1  :::  CBL2: Renal test - 18: patient's weight in kg ::: cbl2  renal test 18  patient s weight in kg ::: NULL ::: NULL ::: NULL ::: NULL ::: laboratory procedures;weighing patient ::: C0022885;C1305866 ::: lbpr;diap ::: patients ::: C0030705 ::: podg ::: Lab Tests Patient;Clinical Attributes
phv00121281.v2  :::  LDH1 & LDH2 AVAILABLE ::: ldh1 & ldh2 available ::: NULL ::: NULL ::: NULL ::: NULL ::: lactate dehydrogenase isoenzyme 2 measurement;lactate dehydrogenase isoenzyme 1 measurement ::: C2697873;C2697872 ::: lbpr;lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00128717.v1  ::: " REASON FOR MISSING DATA: ESTIMATED %CD8, AS A PERCENT OF LYMPHOCYTES " ::: reason for missing data estimated %cd8, as a percent of lymphocytes ::: NULL ::: NULL ::: NULL ::: NULL ::: lymphocyte count measurement ::: C0200635 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00128704.v1  :::  LYMPHOCYTE COUNT  x10^3/ul ::: lymphocyte count x10^3  ul ::: NULL ::: NULL ::: NULL ::: NULL ::: lymphocyte count measurement ::: C0200635 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00128734.v1  :::  PERCENT LYMPHOCYTES IN WHOLE BLOOD THAT ARE CD4+ ::: percent lymphocytes in whole blood that are cd4+ ::: NULL ::: NULL ::: NULL ::: NULL ::: lymphocyte count measurement ::: C0200635 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00027382.v1  :::  CBL2: Renal test - 16: creatinine (urine) value  (mg/dl) ::: cbl2  renal test 16  creatinine  urine  value  magnesium distolingual ::: NULL ::: NULL ::: NULL ::: NULL ::: magnesium measurement, urine ::: C0428308 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00031596.v1  :::  CBL4: Renal test - 16: creatinine (urine) value  (mg/dl) ::: cbl4  renal test 16  creatinine  urine  value  magnesium distolingual ::: NULL ::: NULL ::: NULL ::: NULL ::: magnesium measurement, urine ::: C0428308 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00116107.v2  :::  URINARY MAGNESIUM (UNADJUSTED):DAY 1 ::: urinary magnesium  unadjusted  day 1 ::: NULL ::: NULL ::: NULL ::: NULL ::: magnesium measurement, urine ::: C0428308 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00031078.v1  :::  CBL8: 24-hr urine: urea nitrogen (mg/dl) ::: cbl8  24 heart rate urine  urea nitrogen  magnesium distolingual ::: NULL ::: NULL ::: NULL ::: NULL ::: magnesium measurement, urine ::: C0428308 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Clinical Attributes
phv00031007.v1  :::  CBL9: 24-hr urine: creatinine/urine: value (mg/dl) ::: cbl9  24 heart rate urine  creatinine urine  value  magnesium distolingual ::: NULL ::: NULL ::: NULL ::: NULL ::: magnesium measurement, urine;creatinine finding;urine creatinine measurement ::: C0428308;C1561535;C1318439 ::: lbpr;fndg;lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Clinical Attributes
phv00030392.v1  :::  CBL3: 24-hr urine: creatinine/specimen value (mg/spec) ::: cbl3  24 heart rate urine  creatinine specimen value  magnesium spec ::: NULL ::: NULL ::: NULL ::: NULL ::: magnesium measurement, urine;creatinine finding;urine creatinine measurement ::: C0428308;C1561535;C1318439 ::: lbpr;fndg;lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Clinical Attributes
phv00124417.v1  :::  Mean corpuscular hemoglobin concentration in grams per deciliter ::: mean corpuscular hemoglobin concentration in grams per deciliter ::: NULL ::: NULL ::: NULL ::: NULL ::: mean corpuscular hemoglobin concentration determination ::: C0474535 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00094435.v1  :::  MEAN CORPUSCULAR VOLUME (MCV)     Q13 ::: mean corpuscular volume  mean corpuscular volume  q13 ::: NULL ::: NULL ::: NULL ::: NULL ::: mean corpuscular volume analyses;erythrocyte mean corpuscular volume measurement ::: C0863148;C1948043 ::: lbpr;lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00164625.v1  :::  Mean corpuscular volume in femtoliters at designated visit (may not be baseline) ::: mean corpuscular volume in femtoliters at designated visit  may not be baseline ::: NULL ::: NULL ::: NULL ::: NULL ::: mean corpuscular volume analyses;erythrocyte mean corpuscular volume measurement;health care visit ::: C0863148;C1948043;C1512346 ::: lbpr;lbpr;inbe ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00027329.v1  :::  CBL1: Lipid test - 24: LDL cholesterol (serum) value  (mg/dl) ::: cbl1  lipid test 24  low-density lipoprotein cholesterol  serum  value  magnesium distolingual ::: NULL ::: NULL ::: NULL ::: NULL ::: measurement of serum lipid level;laboratory procedures;serum magnesium finding ::: C0428462;C0022885;C1826990 ::: lbpr;lbpr;fndg ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00027393.v1  :::  CBL2: Lipid test - 22: triglyceride (serum) value  (mg/dl) ::: cbl2  lipid test 22  triglyceride  serum  value  magnesium distolingual ::: NULL ::: NULL ::: NULL ::: NULL ::: measurement of serum lipid level;serum magnesium finding ::: C0428462;C1826990 ::: lbpr;fndg ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00050429.v1  ::: " B8e1. Health care delivery. During the past 6 months have you had laboratory test: stress test, how many times " ::: b8e1 health candidate gene association resource delivery during the past 6 months have you had laboratory test stress test, how many times ::: NULL ::: NULL ::: NULL ::: NULL ::: mental association;obstetric delivery;delivery finding;laboratory procedures;exercise stress test ::: C0004083;C0011209;C0559563;C0022885;C0015260 ::: menp;topp;fndg;lbpr;diap ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Mental or Emotional Finding;Therapeutic or Preventive Procedure;Diagnostic Procedure;Medical History
phv00050676.v1  :::  B8h3. Health care delivery. Urine tests: paid by other insurance ::: b8h3   health candidate gene association resource delivery  urine tests  paid by other insurance ::: NULL ::: NULL ::: NULL ::: NULL ::: mental association;obstetric delivery;urinalysis;delivery finding ::: C0004083;C0011209;C0042014;C0559563 ::: menp;topp;lbpr;fndg ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Mental or Emotional Finding;Therapeutic or Preventive Procedure;Medical History
phv00024694.v3  ::: " HDL PARTICLES 9.4+/-0.6 NM (EXPRESSED AS CHOLESTEROL CONCENTRATIONS IN MG/DL) AND DETERMINED USING NMR, EXAM 4 " ::: high-density lipoprotein particles 9 4+ 0 6 nm expressed as cholesterol concentrations in magnesium distolingual and determined using nmr, exam 4 ::: NULL ::: NULL ::: NULL ::: NULL ::: mental concentration;serum total cholesterol measurement;magnetic resonance imaging;medical examination ::: C0086045;C1445957;C0024485;C0582103 ::: menp;lbpr;diap;hlca ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Mental or Emotional Finding;Healthcare Activity Finding;Diagnostic Procedure
phv00126892.v1  :::  RECALL: niacin ::: recall  niacin ::: NULL ::: NULL ::: NULL ::: NULL ::: mental recall;niacin;vitamin b3 assay;recall:-:point in time:^patient:- ::: C0034770;C0027996;C1142562;C2361119 ::: menp;orch,phsu,vita;lbpr;clna ::: study subject ::: C0681850 ::: grup ::: Medication Patient;Lab Tests Patient;Mental or Emotional Finding
phv00126946.v1  :::  RECALL: glutamic acid ::: recall  glutamic acid ::: NULL ::: NULL ::: NULL ::: NULL ::: mental recall;recall:-:point in time:^patient:-;glutamic acid;glutamate measurement ::: C0034770;C2361119;C0061472;C0523665 ::: menp;clna;aapp,bacs,phsu;lbpr ::: study subject ::: C0681850 ::: grup ::: Medication Patient;Lab Tests Patient;Mental or Emotional Finding
phv00126484.v1  :::  RECALL: pantothenic acid ::: recall  pantothenic acid ::: NULL ::: NULL ::: NULL ::: NULL ::: mental recall;recall:-:point in time:^patient:-;pantothenic acid;blood pantothenic acid analysis;vitamin b5 measurement ::: C0034770;C2361119;C0030342;C0696237;C2700255 ::: menp;clna;orch,phsu,vita;lbpr;lbpr ::: study subject ::: C0681850 ::: grup ::: Medication Patient;Lab Tests Patient;Mental or Emotional Finding
phv00126449.v1  :::  RECALL: total protein ::: recall  total protein ::: NULL ::: NULL ::: NULL ::: NULL ::: mental recall;recall:-:point in time:^patient:-;total protein measurement ::: C0034770;C2361119;C0555903 ::: menp;clna;lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Mental or Emotional Finding
phv00123982.v1  ::: " ISI (0,120) = Metabolic clearance rate / log (Mean Serum Insulin) " ::: isi 0,120 = metabolic clearance rate logarithm mean serum insulin ::: NULL ::: NULL ::: NULL ::: NULL ::: metabolic clearance rate;serum insulin measurement ::: C0025515;C0428357 ::: clna;lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00085016.v2  :::  NATURAL LOG TRANSFORMED C-REACTIVE PROTEIN (CRP) ::: natural logarithm transformed creactive protein  c-reactive protein ::: NULL ::: NULL ::: NULL ::: NULL ::: metaplastic cell transformation;c-reactive protein measurement ::: C1510411;C0201657 ::: patf;lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Medical History
phv00128745.v1  :::  REASON FOR MISSING DATA: PERCENT OF MONOCYTES THAT ARE TF+ IN UNSTIMULATED EXPRESSION ASSAY ::: reason for missing data  percent of monocytes that are tf+ in unstimulated expression assay ::: NULL ::: NULL ::: NULL ::: NULL ::: monocyte count procedure;expression procedure;biological assay;assay ::: C0200637;C0185117;C0005507;C1510438 ::: lbpr;topp;lbpr;lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Therapeutic or Preventive Procedure
phv00165226.v1  :::  Monocytes in absolute numbers at designated visit (may not be baseline). ::: monocytes in absolute numbers at designated visit  may not be baseline ::: NULL ::: NULL ::: NULL ::: NULL ::: monocyte count procedure;health care visit ::: C0200637;C1512346 ::: lbpr;inbe ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00163844.v2  :::  Differential Count (Peripheral Blood): Myelocytes ::: differential count  peripheral blood   myelocytes ::: NULL ::: NULL ::: NULL ::: NULL ::: myelocyte count procedure ::: C0455284 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00142129.v2  ::: " RNA LEVELS: NPPA, Run2, Platelet (TaqmanAssayID : Hs00383231_m1) " ::: ribonucleic acid levels nppa, run2, platelet taqmanassayid hs00383231_m1 ::: NULL ::: NULL ::: NULL ::: NULL ::: n-propionylprocainamide;platelet count measurement ::: C0068273;C0032181 ::: orch,phsu;lbpr ::: study subject ::: C0681850 ::: grup ::: Medication Patient;Lab Tests Patient
phv00126354.v1  :::  LFFQ: niacin (mg) ::: lffq  niacin  magnesium ::: NULL ::: NULL ::: NULL ::: NULL ::: niacin;vitamin b3 assay ::: C0027996;C1142562 ::: orch,phsu,vita;lbpr ::: study subject ::: C0681850 ::: grup ::: Medication Patient;Lab Tests Patient
phv00126616.v1  :::  SFFQ: niacin (mg) ::: sffq  niacin  magnesium ::: NULL ::: NULL ::: NULL ::: NULL ::: niacin;vitamin b3 assay ::: C0027996;C1142562 ::: orch,phsu,vita;lbpr ::: study subject ::: C0681850 ::: grup ::: Medication Patient;Lab Tests Patient
phv00086534.v2  :::  NIACIN AND NICOTINIC ACID ::: niacin and nicotinic acid ::: NULL ::: NULL ::: NULL ::: NULL ::: niacin;vitamin b3 assay;nicotinic acids ::: C0027996;C1142562;C0028049 ::: orch,phsu,vita;lbpr;orch,phsu,vita ::: study subject ::: C0681850 ::: grup ::: Medication Patient;Lab Tests Patient
phv00085923.v2  ::: " HDL CHOLESTEROL, NCEP CATEGORIES " ::: high-density lipoprotein cholesterol, nucleic acid testing categories ::: NULL ::: NULL ::: NULL ::: NULL ::: nucleic acid amplification tests ::: C0200932 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00080994.v3  :::  Interleukin-6 raw OD reading for second well ::: interleukin 6 raw od reading for second well ::: NULL ::: NULL ::: NULL ::: NULL ::: osteochondritis dissecans;reading (activity);reading (datum presentation);interleukin 6 measurement;recombinant interleukin-6 ::: C0029421;C0034754;C1705179;C0919829;C1527132 ::: dsyn;dora;fndg;lbpr;aapp,imft,phsu ::: study subject ::: C0681850 ::: grup ::: Medication Patient;Lab Tests Patient;Daily or Recreational Activity
phv00156660.v2  :::  Osteoprotegerin raw OD reading for second well ::: osteoprotegerin raw od reading for second well ::: NULL ::: NULL ::: NULL ::: NULL ::: osteochondritis dissecans;reading (activity);reading (datum presentation);osteoprotegerin test ::: C0029421;C0034754;C1705179;C1262886 ::: dsyn;dora;fndg;lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Daily or Recreational Activity
phv00049318.v1  :::  O2e. Female/ reproductive: did test indicate pregnancy ::: o2 e  female  reproductive  did test indicate pregnancy ::: NULL ::: NULL ::: NULL ::: NULL ::: oxygen;female;reproduction;laboratory procedures;indicated;pregnancy ::: C0030054;C0015780;C0035150;C0022885;C1444656;C0032961 ::: elii,phsu;fndg;orgf;lbpr;fndg;orgf ::: study subject ::: C0681850 ::: grup ::: Medication Patient;Lab Tests Patient;Medical History
phv00127638.v1  :::  Uric acid character result ::: uric acid character result ::: NULL ::: NULL ::: NULL ::: NULL ::: personality character;experimental result;uric acid measurement (procedure) ::: C0007952;C2825142;C0202239 ::: menp;fndg;lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient;Mental or Emotional Finding
phv00161369.v3  :::  PHENOTYPE SAMPLE WAS SEQUENCED FOR ::: phenotype sample was sequenced for ::: NULL ::: NULL ::: NULL ::: NULL ::: phenotype determination ::: C1285572 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00173446.v1  :::  Granule membrane protein 140 (P-selectin) (sample type: plasma) ::: granule membrane protein 140   pselectin   sample type  plasma ::: NULL ::: NULL ::: NULL ::: NULL ::: plasma protein assay ::: C1168405 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00142180.v2  ::: " RNA LEVELS: CACNB2, Run3, Platelet (TaqmanAssayID : Hs00167861_m1) " ::: ribonucleic acid levels cacnb2, run3, platelet taqmanassayid hs00167861_m1 ::: NULL ::: NULL ::: NULL ::: NULL ::: platelet count measurement ::: C0032181 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00142178.v2  ::: " RNA LEVELS: B2M, Run3, Platelet (TaqmanAssayID : Hs99999907_m1) " ::: ribonucleic acid levels b2 m, run3, platelet taqmanassayid hs99999907_m1 ::: NULL ::: NULL ::: NULL ::: NULL ::: platelet count measurement ::: C0032181 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
phv00142341.v2  ::: " RNA LEVELS: FLJ36031, Run4, Platelet (TaqmanAssayID : Hs00703139_s1) " ::: ribonucleic acid levels flj36031 , run4, platelet taqmanassayid hs00703139_s1 ::: NULL ::: NULL ::: NULL ::: NULL ::: platelet count measurement ::: C0032181 ::: lbpr ::: study subject ::: C0681850 ::: grup ::: Lab Tests Patient
